Martin Rabel

Martin Rabel

Company: Precision NanoSystems

Job title: Services Solution Specialist


Optimised Prime: A Transformative RNA-LNP Vaccine Composition that Scales 9:30 am

LNP formulation and physicochemical characteristics with both messenger RNA (mRNA) and self-amplifying RNA (saRNA)  In vivo immunogenicity of RNA-LNP vaccines against influenza A and SARS-CoV-2   Overcoming scale-up and process development challenges in vaccine development Read more

day: Day One AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.